Relay Therapeutics, Inc. (RLAY): A Bull Case Theory

We came across a bullish thesis on Relay Therapeutics, Inc. (RLAY) on Steve Wagner’s Substack. In this article, we will summarize the bulls’ thesis on RLAY. Relay Therapeutics, Inc. (RLAY)'s share was trading at $3.23 as of 4^th June.

[caption id="attachment_1238262" align="aligncenter" width="768"] A researcher in a laboratory examining a vial of oncolytic herpes simplex virus, demonstrating the company's commitment to finding a cure for cancer.[/caption]

Relay Therapeutics is gaining momentum in oncology, thanks to promising data from its PI3Kα inhibitor RLY-2608, unveiled at...